--- title: What do the studies reveal about weight gain after GLP-1s? description: Learn why weight regain happens after stopping GLP-1s, UK trial data on semaglutide and tirzepatide, and how orforglipron may help maintain weight loss. image: https://blog.tribelle.co.uk/hubfs/Home%20Testing%20Blog%20(2)-3.png --- [Skip to content](https://blog.tribelle.co.uk/weight-regain-after-glp1s-uk-orforglipron-maintenance#main-content) [![TribElle logo – women’s health pharmacy](https://blog.tribelle.co.uk/hs-fs/hubfs/Logo-1.png?width=115&height=115&name=Logo-1.png)Homepage](https://tribelle.co.uk/) - [Treatments](https://tribelle.co.uk/treatments) - [How TribElle Works](https://pharmacy.tribelle.co.uk?hsLang=en) - [About Us](https://pharmacy.tribelle.co.uk/about-us-tribelle-uk?hsLang=en) - Education - [Women's Health Through the Decades](https://pharmacy.tribelle.co.uk/life-stages?hsLang=en) - Blog - [Blog English](https://blog.tribelle.co.uk) - [Blog Punjabi](https://blog.tribelle.co.uk/pa?hsLang=en) - [Blog Telugu](https://blog.tribelle.co.uk/te?hsLang=en) - [Blog Hindi](https://blog.tribelle.co.uk/hi-in?hsLang=en) - [Events](https://pharmacy.tribelle.co.uk/events?hsLang=en) - [FAQs](https://pharmacy.tribelle.co.uk/frequently-asked-questions?hsLang=en) [Sign in](https://tribelle.co.uk/profile) - [Treatments](https://tribelle.co.uk/treatments) - [How TribElle Works](https://pharmacy.tribelle.co.uk?hsLang=en) - [About Us](https://pharmacy.tribelle.co.uk/about-us-tribelle-uk?hsLang=en) - Education - [Women's Health Through the Decades](https://pharmacy.tribelle.co.uk/life-stages?hsLang=en) - Blog - [Blog English](https://blog.tribelle.co.uk) - [Blog Punjabi](https://blog.tribelle.co.uk/pa?hsLang=en) - [Blog Telugu](https://blog.tribelle.co.uk/te?hsLang=en) - [Blog Hindi](https://blog.tribelle.co.uk/hi-in?hsLang=en) - [Events](https://pharmacy.tribelle.co.uk/events?hsLang=en) - [FAQs](https://pharmacy.tribelle.co.uk/frequently-asked-questions?hsLang=en) [Sign in](https://tribelle.co.uk/profile) ![TribElle blog header: What do the studies reveal about weight gain after GLP-1s?](https://blog.tribelle.co.uk/hs-fs/hubfs/Home%20Testing%20Blog%20(2)-3.png?width=1600&height=800&name=Home%20Testing%20Blog%20(2)-3.png) GLP1s Semaglutide UK Tirzepatide UK # What do the studies reveal about weight gain after GLP-1s? ![TribElle Clinical Team](https://blog.tribelle.co.uk/hs-fs/hubfs/Untitled%20design%20(23).png?width=48&height=48&name=Untitled%20design%20(23).png) TribElle Clinical Team February 19, 2026 If you've lost weight on GLP-1 medications like Semaglutide (Wegovy/Ozempic) or Tirzepatide (Mounjaro/Zepbound), congratulations on your progress. But a question we hear constantly is: **what happens when you stop?** Will the weight come back? Understanding this is key to planning your long-term health journey. In this guide, we'll cover: - How much weight GLP-1 drugs can help you lose - What happens after stopping these medicines - Why weight regain often happens - Emerging maintenance therapies like Orforglipron — and what they mean for you   ## How GLP-1 Drugs Help With Weight Loss ### Semaglutide: What the Clinical Trials Show GLP-1 medications like Semaglutide work by reducing appetite and slowing gastric emptying. In clinical trials, participants lost more than **15% of body weight on average** over 68–72 weeks. ### Tirzepatide: Even Greater Results Tirzepatide, which stimulates both GLP-1 and GIP receptors, shows even more potential, with some participants losing roughly **20% or more of their initial weight** in under a year. These medications dramatically outperform traditional diet and exercise alone, and older obesity drugs.   ## What Happens When You Stop GLP-1 Treatment? One key thing to understand: stopping GLP-1 therapy often leads to weight regain, because these drugs influence appetite, satiety, and metabolism rather than permanently changing your body's biological set points. " After stopping GLP-1 and other weight-loss drugs, people regained weight rapidly — about 0.8 kg (~1.8 lb) per month with Semaglutide or Tirzepatide. Many returned to their baseline weight within about 1.5 years. University of Oxford systematic review ### Why Regain Happens When you stop GLP-1 medications: Appetite Returns Hormonal changes reignite hunger signals Calorie Intake Rises Without the appetite suppression working Metabolism Shifts Can revert toward pre-treatment levels **This isn't a "failure."** It reflects the nature of obesity as a chronic condition, where biological signals persist unless countered over time. NICE's own models estimate that benefits from Semaglutide are largely lost within approximately two years after stopping — including improvements in blood pressure and cholesterol.   ## What This Means for People in the UK In the UK, weight-loss GLP-1 drugs are typically prescribed with support from obesity specialists or specialist clinics. Because medications may be time-limited under NICE or private practice pathways, **planning beyond the treatment period is essential.**   ## A New Approach: Orforglipron for Maintenance 💊 Once-Daily Oral Pill 🔬 Eli Lilly Phase III ✅ No Injections Orforglipron is an **oral GLP-1 receptor agonist** — a daily pill developed by Eli Lilly that works on the same pathways as semaglutide and tirzepatide, but without the needle. ### What the ATTAIN-MAINTAIN Trial Found In the Phase III "ATTAIN-MAINTAIN" trial, people who switched from injectable therapies to orforglipron showed strong maintenance of weight loss over 52 weeks: - Participants transitioning from **Wegovy maintained their weight** with minimal regain - Those switching from **Mounjaro maintained significantly more weight loss** vs placebo How Orforglipron Works - Suppresses appetite - Slows digestion - Promotes fullness, without needles, which may improve adherence If approved in the UK, Orforglipron could provide a scalable, longer-term oral maintenance option for people who've already seen results from injectable therapies.   ## Combining Medication With Long-Term Support Even with promising maintenance medications, lasting success typically involves a joined-up approach: 🧠 Behavioural Support 🥗 Dietary Counselling 🏃‍♀️ Regular Activity 👩‍⚕️ Clinical Follow-up   ## Final Takeaways - GLP-1 medications like Semaglutide and Tirzepatide produce powerful weight loss, often exceeding traditional options - Most people regain substantial weight within 1–2 years of stopping if no maintenance strategy is in place - Orforglipron (an oral GLP-1 in development) has shown promise in maintaining weight loss after injectable therapy - Long-term success usually requires medication *plus* lifestyle support Obesity is a chronic condition, planning for the future matters. If you're considering stopping treatment or worried about regaining weight, talk to your GP or specialist about maintenance therapy, lifestyle support, and emerging options like Orforglipron. You deserve a plan that works for the long haul. ### Your Tribe Is Here Whether you're navigating weight management, endometriosis, fertility struggles, or simply seeking better information — our mission is to empower you with resources, education, and community. Because every woman deserves healthcare that sees her, hears her, and heals her. 🌱 Explore treatments ### Explore treatment types that might suit you GLP-1 injections, expert clinical support and a plan built around your body. [See weight loss treatments →](https://pages.tribelle.co.uk/wl-treatments?hsLang=en) [Or browse all TribElle treatments →](https://tribelle.co.uk/treatments) Join the conversation ### You don't have to go through this alone | 👥 Hormonal Migraine Support UK A community for women navigating hormone-related migraines Join group | | --- | | 💛 TribElle Weight Management Support Connect with other women on their weight management journey Join group | ## Share this post [mailto:https%3A%2F%2Fblog.tribelle.co.uk%2Fweight-regain-after-glp1s-uk-orforglipron-maintenance](mailto:https%3A%2F%2Fblog.tribelle.co.uk%2Fweight-regain-after-glp1s-uk-orforglipron-maintenance) ## Keep reading ### [![](https://blog.tribelle.co.uk/hs-fs/hubfs/glp1-guide-featured-image.png?width=2400&height=1260&name=glp1-guide-featured-image.png) GLP1s The Complete GLP1 Guide](https://blog.tribelle.co.uk/mounjaro-vs-wegovy-weight-loss-medications-guide?hsLang=en) ### [Top 7 Supplements for PMOS Symptoms in 2026](https://blog.tribelle.co.uk/top-7-supplements-for-pmos-symptoms-in-2026?hsLang=en) Information - [How TribElle works](https://pages.tribelle.co.uk/?hsLang=en) - [FAQs](https://pharmacy.tribelle.co.uk/frequently-asked-questions?hsLang=en) - [NHS](https://nhspharmacy.tribelle.co.uk/home?hsLang=en) - [Blog](https://blog.tribelle.co.uk/) - [Events](https://pages.tribelle.co.uk/events?hsLang=en) - [About Us](https://pharmacy.tribelle.co.uk/about-us-tribelle-uk?hsLang=en) - [Terms & Conditions](https://pages.tribelle.co.uk/terms-and-conditions?hsLang=en) - [Privacy & Policy](https://tribelle.co.uk/privacy-policy) Treatments - [Weight Loss](https://tribelle.co.uk/treatments/injectable-weight-loss) - [Menopause Management](https://tribelle.co.uk/treatments/hrt) - [Migraine Relief](https://pharmacy.tribelle.co.uk/migraines?hsLang=en) - [See all treatments](https://tribelle.co.uk/treatments) Need some help? - [Contact us](https://tribelle.co.uk/contact-us) - Want to speak to a human being: [0207 362 4107](tel:+442073624107) ![tribelle-mark-transparent](https://blog.tribelle.co.uk/hs-fs/hubfs/Website%20images/TribElle%20Favicon.png?width=262&height=368&name=TribElle%20Favicon.png) - General Pharmaceutical Council Registered (9012688) - Superintendent pharmacist – J Boora (2047130) - Company Number – 16128081 - DUNS Number – 232728742 [![LegitScript Certified](https://blog.tribelle.co.uk/hubfs/Website%20images/Legitscript.png)](https://www.legitscript.com/websites/?checker_keywords=tribelle.co.uk) ![Endometriosis Friendly Employer](https://blog.tribelle.co.uk/hubfs/Website%20images/Endo.jpg) Privacy Policy · Legal · © 2026. All rights reserved. ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "TribElle Clinical Team", "url" : "https://blog.tribelle.co.uk/author/tribelleclinicalteam" }, "dateModified" : "2026-07-07T16:47:40.172Z", "datePublished" : "2026-02-19T10:00:00.000Z", "headline" : "What do the studies reveal about weight gain after GLP-1s?", "image" : [ "https://blog.tribelle.co.uk/hubfs/Home%20Testing%20Blog%20(2)-3.png" ], "mainEntityOfPage" : { "@id" : "https://blog.tribelle.co.uk/weight-regain-after-glp1s-uk-orforglipron-maintenance", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.tribelle.co.uk/hubfs/Logo-1.png" } } } ``` ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "TribElle Clinical Team" }, "dateModified" : "2026-07-07T16:47:40+0000", "datePublished" : "2026-02-19T10:00:00+0000", "description" : "Learn why weight regain happens after stopping GLP-1s, UK trial data on semaglutide and tirzepatide, and how orforglipron may help maintain weight loss.", "headline" : "What do the studies reveal about weight gain after GLP-1s?", "image" : "https://48505236.fs1.hubspotusercontent-na1.net/hubfs/48505236/Home%20Testing%20Blog%20%282%29-3.png", "mainEntityOfPage" : { "@id" : "https://blog.tribelle.co.uk/weight-regain-after-glp1s-uk-orforglipron-maintenance", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://tribelle.co.uk/assets/tribelle-9L69yOUF.svg" }, "name" : "TribElle" } } ```